Clinical Trial Update: Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of Everolimus and OSI-906 in refractory metastatic colorectal cancer has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Everolimus (everolimus)
• OSI-906 (OSI-906)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-01-14